Protalix Collaboration Asset

About Chiesi

Chiesi Farmaceutici is a nearly century-old, family-owned biopharmaceutical company with a strong international footprint, operating in over 30 countries with more than 7,500 employees. Its core therapeutic focus areas are Respiratory, Rare Diseases, and Specialty Care, supported by a global R&D network. A key differentiator is its status as a certified B Corp and Benefit Corporation, embedding sustainability and social responsibility into its corporate DNA with ambitious goals like achieving Net-Zero GHG emissions by 2035.

Therapeutic Areas